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 General Objective Determine the risk factors in the persistence of 
cervical intraepithelial lesions of high and low risk associated with HPV 
infection ablactivo posttreatment. 
Methodology. - Cases and controls, cases were 40 women with persistent 
cervical intraepithelial lesions ablactivo posttreatment. The controls 80 
women with healing at 6 months after treatment were analyzed 
sociodemographic variables, reproductive, sexual, abuse, nutritional and 
associated comorbidity. The analysis was performed using odds ratios, 
confidence interval 95%, x2 test, Student t test. 
Results. - The factors that showed statistically significant difference (p 
<0.05) were: Extension of the lesion greater than 2 cm2. (OR 8.53), presence 
of associated pathology. (OR 6.97), smoking associated with alcoholism (OR 
5.40) Three or more sexual partners in the past three years. (O.R. 5.25), 
Obesity. (OR 4.58), Husband uncircumcised (OR 3.45), Home less sexually 
active at 17 years (OR 2.77), More than two periods (average) annual 
sexually transmitted infections in the last three years (OR 2.53 ), the 
pathology associated with the group of patients who continued the lesion 
were cervicovaginal infection and obesity. 
Conclusion. - It is important to identify factors that may cause persistence of 
lesions to perform a more effective treatment 
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INTRODUCTION 
 Cervical cancer is the second most common cancer in women 
worldwide ( Muñoz 2003, Sanabria 2009, Zaldivar 2012). and is one of the 
leading causes of cancer death in the country, most often occurs in the prime 
of life of women (between 30 and 50 years old) and thus represents a serious 
socio-economic and national health. ( Vargas 1996, Ramón y Cajal 2001 )), 
Infection with human papillomavirus (HPV) is the etiologic factor most 
important risk for development ( Lorincz 1987, Bosch 2002, Zur 2002 ). This 
cosmopolitan infection in approximately 10 to 30% of women of 
reproductive age ( Tirado 2005, Sanabria 2011 ). 
 At present, the treatment of subclinical infection human 
papillomavirus (HPV) causes considerable controversy. Considering its high 
recurrence of spontaneous regression and lack of specific antiviral drugs, 
many authors suggest follow a conservative scheme only treat cervical 
intraepithelial neoplastic lesions. However, other authors suggest the 
treatment of all forms of virus infection to prevent the development of 
cervical cancer (Gall 2001, Scheinfeld 2006 ). 
 The treatments include surgical excision by several methods: 
cryotherapy, laser therapy, the use of 5 - fluorouracil, trichloroacetic acid 
(Sanabria, 2009). The action mechanisms described in these treatments, but 
are believed to cause physical destruction of the infected tissue. In general, 
these treatments have proven effectiveness and different percentages of high 
recurrence, due to the presence of human papillomavirus in clinically normal 
epithelium and varying degrees of damage to the DNA-HPV in each 
treatment ( Gross 2001, Carrozza 2002, Kodner 2004, Hernandez 2008, 
Valerie 2012 ). 
 The need to have available a therapeutic product that is effective and 
helps to eliminate the viral infection also can be applied to large populations, 
it is vital to reduce mortality from cancer Cervical cancer ( Simmons 1981 ). 
 Electrofulguration used as surgical treatment because they have 
shown high effectiveness in the early stages of cervical lesions associated 
with infection by the virus papilomahumano ( Hernandez 2006 ). However, 
there are some factors specific to the type of virus, the patient and the 
environment that influence the lesions persist after surgical treatment, either 
with electro fulguration or cryosurgery, which increases the likelihood of 
malignancy and resulting in cervical cancer ( Ho 1995, Kobayashi  2004 ). 
 Persistence of HPV infection after treatment, is considered as after 6 
months of treatment, even lesions observed by colposcopy or DNA persists 
as observed by molecular biology techniques. 
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 There are several studies that suggest the existence of risk factors for 
persistent HPV lesions before and after treatment, which can be divided: 
A. Acquisition: 
 1. - Risk sexual behavior: age at first intercourse, sexual promiscuity 
and non-use of condoms 
 Two. - High Risk Men: sexual promiscuity, not circumcision, lack of 
hygiene. 
B. - Persistence / regression or cure: 
 1. - Viral. - Genotypes and variants, several types of HPV viral load 
simultaneous 
 Two. - Genetic. - Decreased immune response (immunosuppression), 
genetic susceptibility 
 Three. - Environment. - Age, snuff, oral contraceptives, parity 
C. - invasion 
 1. - Angiogenic factors 
 ( Ho 1995, Kobayashi 2004 ). 
 The persistence of HPV high-risk types can be crucial to the 
development of precancerous and cancerous lesions of the cervix, but not 
necessary for progression ( Schiffman 2003,  Woodman 2007 ). 
 Persistent infection before or after medical or surgical treatment or 
predisposes predicts cervical cancer as reported in a study by Kjaer in 2002, 
with a population of 10,758 women 20-29 years of age. (Kjaer 2002 ) 
 In this study we analyze the epidemiological risk factors involved in 
biological persistence of lesions low-grade cervical intraepithelial associated 
with HPV infection ablactivo posttreatment. 
 
METHODOLOGY 
 We conducted an epidemiological study of cases and controls in the 
Dysplasia Clinic Specialty Hospital for Children and Women SESEQ, 
Dysplasia Clinic Hospital IMSS Regional Delegation and the Center 
Querétaro Querétaro Colposcopic with patients who came in the period from 
1. From January 2010 to June 30, 2012. 
 Records included women over 18 years of age who presented or were 
referred by a medical unit assignment to the Dysplasia Clinic to present any 
abnormality to exfoliative cytology, and colposcopy or biopsy to cervical 
injury data found low-grade cervical intraepithelial associated with HPV 
infection, which merited electrofulguration ablactivo treatment, cryosurgery 
or diathermy loop excision. 
 Group 1 (cases): 40 patients with persistent HPV lesion at 6 months 
after treatment ablactivo 
 Group 2 (control): 80 patients were HPV injury data ablactivo 
posttreatment. 
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 Persistence was defined as the lesion, the entire patient-6th. month of 
treatment was found on colposcopy, and histology / cytology, injury data 
even low-grade cervical intraepithelial as alterations in the transformation 
zone, white epithelium koilocytes and nuclear atypia with perinuclear halo 
 The analysis was performed using descriptive statistical measures of 
central tendency (mean, percentages), dispersion (range, standard deviation). 
With inferential statistical parametric tests such as the T tests for quantitative 
variables, nonparametric tests for qualitative variables and the chi square as 
well as measures of risk and the odds ratio with a confidence level of 95% 
 They accept a value of p <0.05 as statistically significant. 
 
RESULTS 
 The mean age was similar in both groups, in the cases was 32.55 
years (SD 10.22) and controls 32.57 (SD 10.30), with a statistically non-
significant, with p> 0.05, (95 % of -3988 to 3938), the most frequent age 
group in both groups was from 20 to 39, with 72%. 
 In the averages of the other quantitative variables (number of feats, 
weight and height were not statistically significant were worth all p> 0.05. 
 Where did there was a statistically significant p value <0.05 for 
quantitative variables, was body mass index (BMI). Where in the case group, 
the mean was 27.39 (SD: 3.80), while the control group was 25.68 (SD 3.97) 
with an IC 95% of 0109-3294. 
  (Table 1) 
 Dichotomous nominal qualitative variables were analyzed with Chi-
square test and Odds Ratio, the results were: 
 All socio-demographic factors (age, education, marital status, and 
place of residence) had no statistically significant difference (p> 0.05.) 
 Reproductive factors if they had a statistically significant p <0.05 and 
a positive association (OR greater than 1) were: the onset of sexual activity 
before age 17, have had three or more sexual partners in the past three years, 
and the spouse or sexual partner's circumcision. 
 In the group of 16 cases (52%) initiated sexual activity before age 17, 
and in the control group 20 (28%) with a p <0.05, an OR 2.77 (95% C.I. 
1773-6640). 
 The history of having had three or more sexual partners in the past 
three years was in the group of cases of 6 (20%), while in control group 3 
(5%) with a p <0.05, an OR 5.25 (95% C.I. 1215-22685). 
 In the group of women who persisted injury after six months, 27 
(87%) reported that the husband had circumcision, women in the control 
group as reported in 4 (13%) cases the p value was <0.05 The OR of 3.45 
(95% CI 1073-11116) (Table 2) 
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 In addiction, when women reported smoking in an isolated or 
independent were not statistically significant, but when combined reported 
both habits, if I become by far and positive association. 
 The Smoking associated with alcoholism was referred in 5 women 
(14%) of the case group and 2 (3%) in the control group, with p <0.05, an 
OR 5.40 
(C. I. 0993-29406 95%) (Table 3). 
 Nutritional factors obesity was positively associated with statistically 
significant difference in relation to the control group. 
 When comparing the two groups, with a cutoff mass index (BMI) of 
25, there was no statistical difference, but when the cutoff was 30 (obesity) 
then if you had the strength and positive association difference between the 
two groups. 
 In the case group, 26 women (72%) were enrolled overweight or 
obese with a BMI of 25 or more, while in the control group 39 (57%) of 
women had normal weight, with p> 0.05, an OR 1.95 (95% C.I. 0817-4652) 
 When comparing only obesity (BMI of 30 or more) against the 
normal weight. The cases presented in 11 obese patients (52%), while the 
control group 10 (24%), with p <0.05, an OR 4.58 (95% C.I. 0040-0020). 
 Co factors associated morbidity or pathology at the time of diagnosis 
or as background, the fact present with some other disease such as 
hypertension, diabetes, obesity, sexually transmitted infection etc. Just as 
having a history of frequent infections and cervicovaginal showed a 
significant association difference. 
 In the group of women with persistent HPV lesion, 12 (33%) reported 
a history of at least two infections on average over the past three years, while 
the group of women if the injury healed, 11 (15%) denied such a history, 
with a p <0.05, an OR 2.81 (95% C.I. 1096-7244). 
 Also in the case group, 57% reported to course with other pathology 
at the time of diagnosis (diabetes mellitus, systemic hypertension, cervico 
vaginitis, obesity etc.) And in the control group (16% also was studying with 
some pathology, with a p <0.05, an O: R: 6.97 (95% CI 2940-16534). 
 In relation to the extension of the cervical lesion at diagnosis, we 
evaluated the extension, in the group of women with persistent disease. 16 
(52%) had an area greater than 2 cm2. While the control group in 11 cases 
(11%) had that feature, if there was a statistically significant difference with 
a p-value <0.05, OR 8.53 (95% CI 2970-24514). 
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Table   1 
Mean Difference. Quantitative Variable 
 
 Cases Controls P* C. I.   to 95% 
 Means ( S.D. ) Means ( S.D.)    
Age 32,55 (10.22) 32.57 (10.39) 0,990 -3.988 -3.938 
Deeds 2.45 ( 2.26 ) 2.22 ( 1.94 ) 0.573 -0.564-1.014 
Weight        66.72 (11.06) 64.16 (10.48) 0.245 -1.785-6.904 
Size 155.90 (5.37) 158.26 (7.72) 0,104 -5.216 – 0.493 
BMI 27.34 (3.76) 25.68 (3.97) 0.041* 0.071-3.248 
• P: <0.05 Statiscally Significant  (  Student´s for independent samples ) 
 
 
Table   2 
Reproductive Factors 
Number of pregnancies Case N= 40   (%) 
Controls 
N= 80   (%) 
O.R. 
 C.I.  to 95% P 
Two or more pregnancies 26 (65) 46 (57) 1.37 0.625-3.014 0,554 
Nulligravida or 
primiparous 14 (35) 34  (43)    
Total 40 (100) 70 (100)    
Home sex life       
Before 17 years 16 (52) 20 (28) 2.77 1.158-6.640 0,025 
17 years or after 15 (48) 52 (72)     
Total 31 (100) 72 (100)    
Sexual partners in the 
last 3 years 
 
 
     
3 or more partners 6 (20) 3 (5) 5.250 1.215-22.685 0,025 
2 or less partners 24  (80) 63  (95)     
Circumcision of 
husband 
      
Not 27 (87) 43  (66) 3.45 1.073-11.116 0.048 
Yes 4 (13) 22  (34)     
 
*P: < 0.05 Statiscally Significant  (Chi Square) 
Table  3 
Addiction 
Tobacco Cases N= 40 N % 
Controls 
N= 80 N % O.R. C.I. to 95% P 
Positive *** 6 (17) 7 (11) 1,94 0.593-6.182 0,347 
Negative 30 (83) 67 (89)    
 
Total 36 (100) 74 (100)    
Alcoholism       
Positive ** 6(18) 5 (7) 2.64 0.793-8.166 0,176 
Negative 30 (82) 66 (93)    
Total 36 (100) 71 (100)    





 Infection with human papillomavirus is sexually transmitted disease 
most common in the world and is a real public health problem for his very 
close relationship with uterine cervical cancer is a very labile viruses, but 
when it enters the cell or is removed by the female immune system 
represents a real threat for cancer, especially if it is a high risk virus. 
 There are many treatment modalities, all with a great diversity in 
their management methods being more ablactivos the therapeutic efficacy, 
the most used are cryotherapy, electro fulguration, and laser diathermy loop, 
however there are a number of patients who do not respond to treatment, and 
are those that also share some risk factors that prevent complete healing of 
the infection. 
 Several authors researchers have written about the risk factors for 
persistent infection with human papillomavirus, and why some are better or 
not responsive to medical or surgical treatment and have involved various 
factors, from the socio-demographic to sexual and those of each treatment. 
 This study examined various epidemiological and biological factors 
have been mentioned as associated with the persistence of cervical 
intraepithelial lesions associated with HPV infection, ablactivo 
posttreatment. 
 The average age of patients in both study groups after 6 months of 
treatment, was very similar, of 32.55 and 32.57 years for the case and control 
group respectively without statistically significant difference (p> .05). 
Tobacco and 
Alcoholism      
Positive ** 5 (14) 2 (5) 5.40 0.993-29.406 0.045 
Negative 31 (86) 67 (95)    
Total 36 (100) 69 (100)    
*P: < 0.05 Statistically  Significant (Chi Square) 
*** Tobacco and alcoholism  Positive: At least 1 cigarette a day average 
** Alcoholism Positive: Mínimum 3 average drinks per week 
Table  4 
Extension of the lesion at the time of Dx. ( Colposcopy ) 
 Cases N= 40 N % 
Controles 
N= 80 N % 
O.R. 
 




Extensión of the 
lesion      
More than 2 cm2 16 (67) 7 (9) 8.53 2.970-24.514 0.000 
Less than 2 cm2 15 (33) 56 (91)    
Total 31 (100) 63 (100)    
*P: < 0.05 Statiscally Significant (Chi Square) 
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 The factors that were statistically significant (p <0.05) and a positive 
association strength (OR greater than 1) for the persistence of the lesion 
were: 
 1. - Extension of the lesion greater than 2 cm2. (O.R. 8.53) 
 Two. - Presence of associated pathology. (O.R. 6.97) 
 3. - Smoking associated alcoholism. (O.R. 5.40) 
 April. - Three or more sexual partners in the past three years. (O.R. 
5.25) 
 May. - Obesity (O.R. 3.41) 
 June. - Spouse uncircumcised (O.R. 3.45) 
 July. - Over two periods (average) annual sexually transmitted 
infections in the last three years (OR 2.81) 
 August. - Home of sexually active less than 17 years (OR 2.77) 
 9. - The pathology associated with the group of patients who 
continued the lesion were cervicovaginal infection and obesity. 
 It is desirable that during the development of the medical history of 
the woman who goes by infection with Human Papillomavirus and treatment 
required ablactivo have in mind all the factors that increase the likelihood of 
persistence of the lesion, as demonstrated by literature and in the present 
work to influence those who are susceptible to change as obesity, sexually 
transmitted infections, smoking, alcoholism etc more. 
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